Comparing two acid-reducing treatments after bleeding ulcer repair
Treatments studied
Part of Digestive system clinical trials.
This study compares two treatments that reduce stomach acid after a bleeding ulcer has been repaired with an endoscope. It aims to find which one is better at preventing the ulcer from bleeding again.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and currently in the hospital.
- You have had an upper digestive tract ulcer that was bleeding.
- You had a procedure called an endoscopy to stop the bleeding.
- Your condition must be considered high-risk, as measured by a scoring system called Rockall (score of 6 or higher).
- You must not have any other cause for the bleeding, such as from veins in the esophagus or other conditions.
- You must not have severe kidney or liver disease or have had an allergic reaction to the study drugs in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines—vonoprazan and esomeprazole—to see which is better at healing acid damage to the esophagus (erosive esophagitis). If you have had heartburn and an endoscopy confirmed inflammation, you may be eligible for this study.
This study compares two medications, rabeprazole and vonoprazan, to see which one works better at preventing ulcers that can form after a procedure to treat varices (enlarged veins) in the esophagus. If you have cirrhosis and varices, this trial may help reduce pain and bleeding after your treatment.
This trial compares two medicines that reduce stomach acid to help heal ulcers that form after a procedure called ESD, which removes abnormal stomach tissue. The goal is to see if one medicine works better and has fewer side effects.
This study compares two acid-reducing medications, keverprazan and pantoprazole, to see which is better at stopping bleeding from the upper digestive tract (stomach or food pipe). If you have had bleeding in your stomach or intestines, this trial could help determine the most effective treatment for you.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.